AVNS News and Press, Avanos Medical Inc. From 08/05/25

2025-08-05 13:27:14 ET More on Avanos Medical Avanos Medical, Inc. 2025 Q2 - Results - Earnings Call Presentation Avanos Medical, Inc. (AVNS) Q2 2025 Earnings Call Transcript Avanos Medical Non-GAAP EPS of $0.17 beats by $0.02, revenue of $175M beats by $9.5M ...

2025-08-05 13:26:44 ET Avanos Medical, Inc. (AVNS) Q2 2025 Earnings Conference Call August 05, 2025 9:00 AM ET Company Participants David C. Pacitti - Chief Executive Officer Jason M. Pickett - Interim CFO, VP of Tax & Treasurer Scott Galovan - Senior Vice Pr...

SOPHiA GENETICS SA (SOPH) is expected to report for Q2 2025 Investors Title Company (ITIC) is expected to report for Q2 2025 Safehold Inc. (SAFE) is expected to report $0.39 for Q2 2025 First Guaranty Bancshares Inc. (FGBI) is expected to report $-0.2 for Q2 2025 United Fire Group...

Avanos Medical Announces Appointment of Scott Galovan as Senior Vice President, Chief Financial Officer; David Pacitti Appointed to Board of Directors PR Newswire ALPHARETTA, Ga. , Aug. 5, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS), a leading med...

2025-08-05 06:39:09 ET More on Avanos Medical Seeking Alpha’s Quant Rating on Avanos Medical Historical earnings data for Avanos Medical Financial information for Avanos Medical Read the full article on Seeking Alpha For further details see: ...

Avanos Medical, Inc. Announces Second Quarter 2025 Results PR Newswire ALPHARETTA, Ga. , Aug. 5, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported second quarter 2025 financial results. "Building off our first quarter resu...

Avanos Medical Inc. (AVNS) is expected to report $0.18 for Q2 2025

2025-07-31 16:32:53 ET More on Avanos Medical Avanos Medical Non-GAAP EPS of $0.26, revenue of $167.5M Seeking Alpha’s Quant Rating on Avanos Medical Historical earnings data for Avanos Medical Read the full article on Seeking Alpha For further...

Avanos Announces Divestiture of Hyaluronic Acid Product Line to Channel-Markers Medical PR Newswire ALPHARETTA, Ga. , July 31, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS), announced today the divestiture of its Hyaluronic Acid (HA) product line to...

Avanos Medical, Inc. to Webcast Conference Call Discussing Second Quarter 2025 Financial Results PR Newswire ALPHARETTA, Ga. , July 24, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and busine...